Findings

What do systematic reviews say?

5 questions · 6 findings · 1 reviews · Acute Respiratory Infections

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 50%Moderate 3 · 50%High 0 · 0%

Antihistamine‐decongestant vs placebo

Global evaluation · otherwise healthy adults and children with common cold symptoms

Antihistamine‐decongestant probably leads to lower global evaluation compared with placebo (moderate certainty).

1 finding from 1 review

Oral antihistamine‐decongestant‐analgesic combinations for the common cold 2022 · Cochrane Headline outcomes only
OR 0.31 [0.2, 0.48]
6 studies · 565 participants
Moderate

Antihistamine‐analgesic vs placebo

Global evaluation · otherwise healthy adults and children with common cold symptoms

Antihistamine‐analgesic probably leads to lower global evaluation compared with placebo (moderate certainty).

1 finding from 1 review

Oral antihistamine‐decongestant‐analgesic combinations for the common cold 2022 · Cochrane Headline outcomes only
OR 0.33 [0.23, 0.46]
1 study · 582 participants
Moderate

Analgesic‐decongestant vs placebo

Global evaluation · otherwise healthy adults and children with common cold symptoms

Analgesic‐decongestant probably leads to lower global evaluation compared with placebo (moderate certainty).

1 finding from 1 review

Oral antihistamine‐decongestant‐analgesic combinations for the common cold 2022 · Cochrane Headline outcomes only
OR 0.28 [0.15, 0.52]
1 study · 181 participants
Moderate

Antihistamine‐analgesic‐decongestant vs placebo

Global evaluation · otherwise healthy adults and children with common cold symptoms

Antihistamine‐analgesic‐decongestant showed no clear difference in global evaluation: after 3 days of treatment (included children 2 to… compared with placebo (low certainty).

2 findings from 1 review

Oral antihistamine‐decongestant‐analgesic combinations for the common cold 2022 · Cochrane Headline outcomes only
OR 0.34 [0.09, 1.31]
1 study · 109 participants
Low
Oral antihistamine‐decongestant‐analgesic combinations for the common cold 2022 · Cochrane Headline outcomes only
OR 0.47 [0.33, 0.67]
2 studies · 548 participants
Low

Antihistamine‐analgesic‐decongestant vs placebo

Global evaluation: after 5 days of treatment (included children 2 to 12 years old only) · otherwise healthy adults and children with common cold symptoms

Antihistamine‐analgesic‐decongestant showed no clear difference in global evaluation: after 5 days of treatment (included children 2 to… compared with placebo (low certainty).

1 finding from 1 review

Oral antihistamine‐decongestant‐analgesic combinations for the common cold 2022 · Cochrane Headline outcomes only
OR 1.17 [0.49, 2.77]
1 study · 83 participants
Low